Prevention of breast cancer-related lymphedema with tacrolimus

Odense University Hospital0 个研究点目标入组 40 人开始时间: 2018年10月3日最近更新: 2020年3月18日

适应症

试验速览

暂无简介。

•Diagnosticeret med brystkræft og skal have fjernet samtlige lymfeknuder i armhulen ved operation, som led i kræftbehandlingen.
•Indikationen for fjernelse af alle lymfeknuder i armhulen.
•Alder mellem 18-75 år
•Postmopausal (udebleven menstruation i min. 12 mdr.) eller kontinuerligt brug af svangerskabsforebyggende midler (Spiral, p-piller, implantat, transdermal depotplastre, vaginalring eller depotinjektion)
•God almentilstand (ASA score 1 eller 2)
•Modsatte arm er normal (intet lymfødem)
•Forstår undersøgelsens formål og natur og giver skriftligt informeret samtykke.
•Kan læse og forstå dansk.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 30
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 10

•Pregnant, breastfeeding or wishing to conceive within the next year.
•Bilateral breast cancer
•Known allergy to Tacrolimus or the macrolide type antibiotics.
•Removal of lymph nodes from the opposite armpit.
•Known lymphedema in parallel or opposite arm
•Other malignant disease in addition to breast cancer (non-melanoma skin cancer)
•In medical treatment for diabetes mellitus.
•Known with psychiatric disorder that may influence participation in the study.
•Known with poor renal or hepatic function.

发起方